Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis

Modern Rheumatology

Volumn 17, Issue 1, 2007, Pages 72-74

  Yamamoto, Motohisa ^a   Takahashi, Hiroki ^a   Wakasugi, Hideki ^a   Sukawa, Yasutaka ^a   Saito, Mayuko ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Yamamoto, Hiroyuki ^a   Shinomura, Yasuhisa ^a   Imai, Kohzoh ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Elderly; Etanercept; Leukoencephalopathy; Rheumatoid arthritis

Indexed keywords

ACICLOVIR; ACTARIT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AURANOFIN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLOBULIN; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; RIFAMPICIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADL DISABILITY; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; BABINSKI REFLEX; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONVULSION; DISEASE SEVERITY; DISORIENTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; INTERSTITIAL PNEUMONIA; JAPANESE; JC VIRUS; KNEE ARTHROPLASTY; LEUKOCYTOSIS; LEUKOENCEPHALOPATHY; LUNG TUBERCULOSIS; MALAISE; MENINGOENCEPHALITIS; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURISY; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVECTOMY; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; CEREBROSPINAL FLUID; CHEMICALLY INDUCED DISORDER; COMA; DEMENTIA; DRUG ANTAGONISM; HOSPITALIZATION;

AGED; ARTHRITIS, RHEUMATOID; COMA; DEMENTIA; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247581330     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0530-2     Document Type: Article

References (17)

1. Guidelines for the proper use of anti-TNF drugs against rheumatoid arthritis. Japanese College of Rheumatology. http://www.ryumachi-jp.com/ Ryumachi/Secure/kaiin/medical/brm_guideline.html
2. AK Imperato CO Bingham III SB Abramson 2004 Overview of benefit/risk of biological agents Clin Exp Rheumatol 22 Suppl 35 S108-14 15552523 1:STN:280:DC%2BD2crns1aitQ%3D%3D
3. JC Roos AJ Ostor 2006 Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection Arthritis Rheum 54 381-2 16385537 10.1002/ art.21688
4. KE Astrom EL Mancall EP Richardson Jr 1958 Progressive multifocal leuko-encephalopathy: A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease Brain 81 93-111 13523006 10.1093/brain/81.1.93 1:STN:280:CyeD28rptVU%3D
5. BL Padgett DL Walker GM ZuRhein RJ Eckroade BH Dessel 1971 Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy Lancet 1 7712 1257-69 4104715 10.1016/ S0140-6736(71)91777-6 1:STN:280:CS6B28%2FgvFw%3D
6. A Stolt K Sasnauskas P Koskela M Lehtinen J Dillner 2003 Seroepideminology of the human polyomaviruses J Gen Virol 84 1499-504 12771419 10.1099/vir.0.18842-0 1:CAS:528:DC%2BD3sXks1GmtLw%3D
7. Kimura A, Ueyama H, Kimura N, Fujimoto S, Kumamoto T. Progressive multifocal leukoencephalopathy in an HTLV-1 carrier. Clin Neurol Neurosurg 2005 Oct 26; [Epub ahead of print]
8. F Ahmed T Aziz LD Kaufman 1999 Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus J Rheumatol 26 1609-12 10405953 1:STN:280:DyaK1MzjsVChtw%3D%3D
9. K Subsai S Kanoksri C Siwaporn L Helen O Kanokporn P Wantana 2006 Neurological complications in AIDS patients receiving HAART: A 2-year retrospective study Eur J Neurol 13 233-9 16618338 10.1111/ j.1468-1331.2006.01178.x 1:STN:280:DC%2BD283ht1KqsQ%3D%3D
10. A Antinori A Cingolani P Lorenzini ML Giancola I Uccella S Bossolasco 2003 Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA) J Neurovirol 9 Suppl 1 47-53 12709872 1:CAS:528:DC%2BD3sXksFOrsLw%3D
11. IJ Koralnik 2004 New insights into progressive multifocal leukoencephalopathy Curr Opin Neurol 17 365-70 15167073 10.1097/ 00019052-200406000-00019
12. G van Assche M Van Ranst R Sciot B Dubois S Vermeire M Noman 2005 Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 362-8 15947080 10.1056/NEJMoa051586 1:CAS:528:DC%2BD2MXms1Kntrk%3D
13. BK Kleinschmiedt-DeMasters KL Tyler 2005 Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon γ-1a for multiple sclerosis N Engl J Med 353 369-74 10.1056/NEJMoa051782
14. A Langer-Gould SW Atlas AJ Green AW Bollen D Pelletier 2005 Progressive multifocal leukoencephalopathy in a patient treated with natalizumab N Engl J Med 353 375-81 15947078 10.1056/NEJMoa051847 1:CAS:528:DC%2BD2MXms1Kntrc%3D
15. TA Yousry EO Major C Ryschkewitsch G Fahle S Fischer J Hou 2006 Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 924-33 16510746 10.1056/ NEJMoa054693 1:CAS:528:DC%2BD28XitVertLs%3D
16. RM Ransohoff 2005 Natalizumab and PML Nat Neurosci 8 127516189528 10.1038/nn1005-1275 1:CAS:528:DC%2BD2MXhtVeqsrfF
17. N Mohan ET Edwards TR Cupps PJ Oliverio G Sandberg H Crayton 2001 Demyelination occurring during anti-tumor necrosis factor α therapy for inflammatory arthritides Arthritis Rheum 44 2862-9 11762947 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W 1:CAS:528:DC%2BD38XislCltA%3D%3D